characteristics of patients included in our sample, grouped by receipt of brain imaging. Categorical variables were reported as counts and percentages, and groups were compared using chi-square tests for significance. Continuous variables were reported as medians
Search Results
Overuse of Diagnostic Brain Imaging Among Patients With Stage IA Non–Small Cell Lung Cancer
Michael G. Milligan, Angel M. Cronin, Yolonda Colson, Kenneth Kehl, Debra N. Yeboa, Deborah Schrag, and Aileen B. Chen
Predictors of Distant Metastases in Triple-Negative Breast Cancer Without Pathologic Complete Response After Neoadjuvant Chemotherapy
William R. Kennedy, Christopher Tricarico, Prashant Gabani, Ashley A. Weiner, Michael B. Altman, Laura L. Ochoa, Maria A. Thomas, Julie A. Margenthaler, Souzan Sanati, Lindsay L. Peterson, Cynthia X. Ma, Foluso O. Ademuyiwa, and Imran Zoberi
for all statistical analyses. Results Patients and Treatment Characteristics A total of 153 patients with a median follow-up of 4.04 years (range, 0.51–13.97 years) were included in the study cohort. Patient characteristics and treatment strategies are
Chemotherapy With or Without Anti-EGFR Agents in Left- and Right-Sided Metastatic Colorectal Cancer: An Updated Meta-Analysis
Zi-Xian Wang, Hao-Xiang Wu, Ming-Ming He, Ying-Nan Wang, Hui-Yan Luo, Pei-Rong Ding, Dan Xie, Gong Chen, Yu-Hong Li, Feng Wang, and Rui-Hua Xu
clinical outcomes of left- and right-sided CRC tumors. 2 – 7 These differing characteristics are associated with differential prognosis, and patients with right-sided CRC are reported to have a worse prognosis. 8 , 9 A recent meta-analysis including 14
Screening and Stepped Care Targeting Psychological Distress in Patients With Metastatic Colorectal Cancer: The TES Cluster Randomized Trial
Claudia S.E.W. Schuurhuizen, Annemarie M.J. Braamse, Aartjan T.F. Beekman, Pim Cuijpers, Mecheline H.M. van der Linden, Adriaan W. Hoogendoorn, Hans Berkhof, Dirkje W. Sommeijer, Vera Lustig, Suzan Vrijaldenhoven, Haiko J. Bloemendal, Cees J. van Groeningen, Annette A. van Zweeden, Maurice J.D.L. van der Vorst, Ron Rietbroek, Cathrien S. Tromp-van Driel, Machteld N.W. Wymenga, Peter W. van der Linden, Aart Beeker, Marco B. Polee, Erdogan Batman, Maartje Los, Aart van Bochove, Jan A.C. Brakenhoff, Inge R.H.M. Konings, Henk M.W. Verheul, and Joost Dekker
-described effective interventions using a stepped care–oriented approach (S). At baseline, the TES and CAU groups were comparable regarding sociodemographic and most clinical characteristics ( Table 1 and supplemental eTable 3 ). Patients in the TES arm received
Does Adjuvant Bisphosphonate in Early Breast Cancer Modify the Natural Course of the Disease? A Meta-Analysis of Randomized Controlled Trials
Davide Mauri, Antonis Valachis, Nikolaos P. Polyzos, Lamprini Tsali, Dimitris Mavroudis, Vassilis Georgoulias, and Giovanni Casazza
analyses could be retrieved from only 13 studies. 10 – 12 , 21 – 30 A flow chart indicating the identification of randomized controlled trials for inclusion in the meta-analysis is reported in Figure 1 . Characteristics of Trials Table 1
Efficacy of Oral Cryotherapy During Oxaliplatin Infusion in Preventing Oral Thermal Hyperalgesia: A Randomized Trial
Brittany Bauman, Rosemarie Mick, Eileen Martinez, Theresa M. Lawless, Lindsey Zinck, Paige Sinclair, Mary Fuhrer, Mark O’Hara, Charles J. Schneider, Peter O’Dwyer, John Plastaras, Ursina Teitelbaum, and Kim A. Reiss
5% type I error rate. Baseline characteristics were summarized for each treatment arm. Continuous variables were summarized by mean, standard error, and range. Categorical variables were summarized by frequency and percentage. Continuous variables
Breast Cancer Diagnostics, Therapy, and Outcomes in Sub-Saharan Africa: A Population-Based Registry Study
Walburga Yvonne Joko-Fru, Mirko Griesel, Nikolaus Christian Simon Mezger, Lucia Hämmerl, Tobias Paul Seraphin, Jana Feuchtner, Henry Wabinga, Guy N’da, Assefa Mathewos, Bakarou Kamaté, Judith Nsonde Malanda, Freddy Houéhanou Rodrigue Gnangnon, Gladys Chebet Chesumbai, Anne Korir, Cesaltina Lorenzoni, Annelle Zietsman, Margaret Ziona Borok, Biying Liu, Christoph Thomssen, Paul McGale, Ahmedin Jemal, Donald Maxwell Parkin, and Eva Johanna Kantelhardt
evidence of receiving any CDT For patients with metastatic disease, we described the therapy they received (see Table 1 for therapies). Table 1. Therapy Characteristics for Patients With BC by Stage at Diagnosis Assessing Loss to Follow
Response Rates and Durations of Response for Biomarker-Based Cancer Drugs in Nonrandomized Versus Randomized Trials
Bishal Gyawali, Elvira D’Andrea, Jessica M. Franklin, and Aaron S. Kesselheim
patient and disease characteristics closest to those of the RCT. If a non-RCT contained multiple arms for different doses or different histologies, we chose the dose and tumor cohort with the nearest match to the RCT. If the trial characteristics were
Early and Midtreatment Mortality in Palliative Radiotherapy: Emphasizing Patient Selection in High-Quality End-of-Life Care
Matthew S. Ning, Prajnan Das, David I. Rosenthal, Bouthaina S. Dabaja, Zhongxing Liao, Joe Y. Chang, Daniel R. Gomez, Ann H. Klopp, G. Brandon Gunn, Pamela K. Allen, Paige L. Nitsch, Rachel B. Natter, Tina M. Briere, Joseph M. Herman, Rebecca Wells, Albert C. Koong, and Mary Frances McAleer
categorical variables. Statistical analyses were performed using SPSS Statistics, version 24 (IBM Corp). For all tests, a P value ≤ .050 was considered statistically significant. Results Patient Characteristics Among 20,534 total RT courses delivered at our
Local Recurrence and Disease-Free Survival After Transanal Total Mesorectal Excision: Results From the International TaTME Registry
Sapho X. Roodbeen, Marta Penna, Susan van Dieren, Brendan Moran, Paris Tekkis, Pieter J. Tanis, Roel Hompes, and on behalf of the International TaTME Registry Collaborative
procedures, or diagnosis other than adenocarcinoma on final histopathology; and 1,001 were treated in centers where >10% of their cases had ≥1 missing values for the main outcome parameters. Patient and tumor characteristics are outlined in Table 1 . Overall
